Literature DB >> 19464351

Quantitative analysis of the expression of the glutamate-aspartate transporter and identification of functional glutamate uptake reveal a role for cochlear fibrocytes in glutamate homeostasis.

D N Furness1, D M Lawton, S Mahendrasingam, L Hodierne, D J Jagger.   

Abstract

There are several subtypes of fibrocyte in the spiral ligament and spiral limbus of the cochlea that may contribute to fluid homeostasis. Immunocytochemical data suggest that these fibrocytes possess the glutamate-aspartate transporter, GLAST, as do supporting cells around the hair cells. However, functional glutamate uptake has not been demonstrated in fibrocytes. We used confocal and post-embedding immunogold electron microscopy to confirm that GLAST is expressed in adult fibrocytes of CD-1 mice with a relative expression: spiral limbus fibrocytes>type II>V>IV>I spiral ligament fibrocytes. Because they were sparsely present in most samples, type III fibrocytes were assessed only in one sample where their GLAST levels were similar to type I. Type II, type V and spiral limbus fibrocytes have many fine cellular processes that increase their surface area, those of the latter two coming into direct contact with perilymph, and type V fibrocytes contain the most glutamate. These data imply that glutamate uptake occurs in the fibrocytes. We assessed uptake of D-aspartate (a glutamate analogue) together with GLAST expression immunocytochemically and electrophysiologically. D-aspartate accumulated into GLAST expressing fibrocytes in vitro and evoked currents blockable by the GLAST inhibitor D,L-threo-beta-benzyloxyaspartate (TBOA), similar to those of supporting cells around inner hair cells. Currents were strongest in spiral limbus fibrocytes, progressively lower in type V and type II fibrocytes, and were negligible in type I fibrocytes in accordance with the relative expression levels of GLAST. We conclude that in addition to their known homeostatic functions, fibrocytes, in particular spiral limbus, type II and type V fibrocytes play a role in glutamate homeostasis in the cochlea.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464351     DOI: 10.1016/j.neuroscience.2009.05.036

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  Contractility in type III cochlear fibrocytes is dependent on non-muscle myosin II and intercellular gap junctional coupling.

Authors:  John J Kelly; Andrew Forge; Daniel J Jagger
Journal:  J Assoc Res Otolaryngol       Date:  2012-04-05

2.  Subcellular distribution and relative expression of fibrocyte markers in the CD/1 mouse cochlea assessed by semiquantitative immunogold electron microscopy.

Authors:  Shanthini Mahendrasingam; Catherine Bebb; Ella Shepard; David N Furness
Journal:  J Histochem Cytochem       Date:  2011-11       Impact factor: 2.479

3.  Immunohistochemical localization of Nrf2 in the human cochlea.

Authors:  Kumiko Hosokawa; Seiji Hosokawa; Gail Ishiyama; Akira Ishiyama; Ivan A Lopez
Journal:  Brain Res       Date:  2018-07-05       Impact factor: 3.252

4.  The expression of glutamate aspartate transporter (GLAST) within the human cochlea and its distribution in various patient populations.

Authors:  Sameer Ahmed; Nopawan Vorasubin; Ivan A Lopez; Seiji Hosokawa; Gail Ishiyama; Akira Ishiyama
Journal:  Brain Res       Date:  2013-07-11       Impact factor: 3.252

Review 5.  The cochlear CRF signaling systems and their mechanisms of action in modulating cochlear sensitivity and protection against trauma.

Authors:  Christine E Graham; Johnvesly Basappa; Sevin Turcan; Douglas E Vetter
Journal:  Mol Neurobiol       Date:  2011-09-11       Impact factor: 5.590

Review 6.  The cochlea as an independent neuroendocrine organ: expression and possible roles of a local hypothalamic-pituitary-adrenal axis-equivalent signaling system.

Authors:  Johnvesly Basappa; Christine E Graham; Sevin Turcan; Douglas E Vetter
Journal:  Hear Res       Date:  2012-03-29       Impact factor: 3.208

7.  Relative time course of degeneration of different cochlear structures in the CD/1 mouse model of accelerated aging.

Authors:  Shanthini Mahendrasingam; Jamie A Macdonald; David N Furness
Journal:  J Assoc Res Otolaryngol       Date:  2011-03-12

8.  A rare genomic duplication in 2p14 underlies autosomal dominant hearing loss DFNA58.

Authors:  Karina Lezirovitz; Gleiciele A Vieira-Silva; Ana C Batissoco; Débora Levy; Joao P Kitajima; Alix Trouillet; Ellen Ouyang; Navid Zebarjadi; Juliana Sampaio-Silva; Vinicius Pedroso-Campos; Larissa R Nascimento; Cindy Y Sonoda; Vinícius M Borges; Laura G Vasconcelos; Roberto M O Beck; Signe S Grasel; Daniel J Jagger; Nicolas Grillet; Ricardo F Bento; Regina C Mingroni-Netto; Jeanne Oiticica
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

9.  Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea.

Authors:  Evangelia Tserga; Rocio Moreno-Paublete; Heela Sarlus; Erik Björn; Eduardo Guimaraes; Christian Göritz; Christopher R Cederroth; Barbara Canlon
Journal:  FASEB J       Date:  2020-08-24       Impact factor: 5.191

10.  Auditory synaptopathy in mice lacking the glutamate transporter GLAST and its impact on brain activity.

Authors:  Evangelia Tserga; Peter Damberg; Barbara Canlon; Christopher R Cederroth
Journal:  Prog Brain Res       Date:  2020-05-29       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.